Clinical Trial Update: Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 head-to-head clinical trial comparing two Ga-68 PET tracers (68Ga-MGS5 vs 68Ga-DOTATATE) in patients with medullary thyroid carcinoma to evaluate imag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)
• 68Ga-MGS5

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Medullary Thyroid Carcinoma | Phase 1 | Status: RECRUITING